Publication: 3972

Publication: 3972

Impact of Imaging Study Frequency on Progression Free Survival in Alliance Clinical Trials Enrolling Patients with Untreated Follicular Lymphoma

URL

URL

Google Scholar

Citation:: j Clin Oncol vol 41 (16S) 7520

Meeting Instance:: ASCO 2023
Year:: 2023
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Meta-Analysis
Data Sharing:: Alliance-data-source,-internal-user
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 4120

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:: Celegene (CALGB 50803), GSK (CALGB 50901 and 50904)
Grants:: U10 CA180821, U10 CA180882

Corr. Author:
Authors:: Sarah C. Rutherford Jun Yin Levi Pederson Kristie A. Blum Peter Martin Sing-Ho Jung Barbara Grant Cara Rosenbaum Bruce D. Cheson Nancy L. Bartlett Sumithra Mandrekar John P. Leonard

Networks:: CAPITAL, LAPS-IL057, LAPS-MN026, LAPS-MO011, LAPS-OH007, NY018

Study: Alliance-A151737
Multiple Studies, or Legacy Studies in Alliance Study:: Alliance-A051103, CALGB-50701, CALGB-50803, CALGB-50901, CALGB-50904
Phases:: N/A, 1, 2

Keywords: